Tesimide

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C16H15NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier WHO633E898, chemically known as 1,3(2h,4h)-isoquinolinedione, 5,6,7, 8-tetrahydro-4-(phenylmethylene)- but generally known as tesimide, which bears US NIH Compound Identifier 5384729. European Medicines Agency schedules Tesimide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10935MIG. The term TESIMIDE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 24, No. 11 1970, List 10). TESIMIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule tesimide under HS 29251995 and SITC 51482. As of Q4 2014, TESIMIDE remains the US FDA Preferred Term for this commodity. Tesimide bears US NLM identifiers UMLS ID C2827339 and NCI Concept Code C84197. SMILES: O=C1NC(=O)C(=C\C2CCCCC2)/C2=C1CCCC2.